...sodium, and methocarbamol, all which come with safety risks when not used appropriately. Furthermore, these drugs can interact with an individual’s overall drug regimen, leading to additional safety concerns, including...
...sodium, and methocarbamol, all which come with safety risks when not used appropriately. Furthermore, these drugs can interact with an individual’s overall drug regimen, leading to additional safety concerns, including...
...state-level opioid policies by comparing outcomes in states that adopted such policies against states that did not, while accounting for other factors that could have influenced changes in opioid utilization...
...This last note is particularly troublesome for workers’ comp claims, where opioid pain medications or other high-risk prescription drugs may be prescribed, which come with inherent risks that are increased...
The wide-reaching concerns posed by opioids to patient safety and claim outcomes are well understood within workers’ compensation, and we have implemented many effective measures as an industry to tackle...
The National Council on Compensation Insurance (NCCI) published Firefighters and First Responders: 2023 Update on Presumptive Workers’ Comp Benefits, a new research brief that reviews recent legislative developments surrounding presumptions...
...day7-8 69% experience burnout symptoms9 59% take less paid time off (PTO)9 37% feel isolated and concerned about their performance10 36% said their stress levels increased10 Continue reading the article...
...increase the potential for more drug approvals to come in the next few years. And while there are federal complications as most psychedelics are classified as Schedule I drugs, there...
...- 10mL Vial to the consumer level due to a customer product complaint for the presence of white particles floating inside of the vial. Methocarbamol is a muscle relaxant that...
...compliance reward system, such as earning special icons on a prize wheel within the app. The FDA reviewed a multi-site, unblinded, controlled 12-week clinical trial of 170 patients who received...
If you missed it in October, the American Gastroenterology Association (AGA) issued new guidelines on opioid-induced constipation (OIC), providing guidance on managing pharmacotherapy. OIC is a common side effect of opioid therapy,...
